No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
45 and older
Sex
Female
Study type
Interventional
Purpose
Screening
Participants needed
150 (estimated)
Sponsor
Emory University · Other
Who this trial is looking for
This trial is looking for post-menopausal women with chest pain to study how stress affects heart function. Participants will take part in tests and fill out surveys about their health and stress levels.
Are You a Good Fit for This Trial?
You may be able to join if
I am a post-menopausal woman aged 45 or older
I have chest pain
I am willing to undergo mental stress testing
I can give informed consent
You may not be able to join if
I have a history of significant heart or blood vessel problems
I have severe uncontrolled high blood pressure
I am currently pregnant
I have severe lung, kidney, liver, or mental health issues
I have had a heart attack or unstable angina in the past month
I have conditions that prevent safe testing
I have a life expectancy of less than 2 years
I cannot consent to participate
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Coronary Microvascular Dysfunction (CMD) occurs when there are problems in the small blood vessels/arteries of the heart, resulting in persistent chest pain that affects women.
There are an estimated 3 million women in the US with CMD and about 100,000 new cases annually. This research will investigate whether the stress response physiology and autonomic function in response to mental stress are …
Coronary Microvascular Dysfunction (CMD) occurs when there are problems in the small blood vessels/arteries of the heart, resulting in persistent chest pain that affects women.
There are an estimated 3 million women in the US with CMD and about 100,000 new cases annually. This research will investigate whether the stress response physiology and autonomic function in response to mental stress are different in women with CMD compared to other groups. The autonomic nervous system (ANS) controls normally involuntary activities, such as heart rate, respiration (breathing), body temperature, blood pressure, and urinary function. This study will also examine how chronic and daily life mental stress affects the heart and blood vessels.
Participants from this study will be recruited mainly from Emory Healthcare-associated hospitals, the Emory Heart Disease Center for Prevention, and Emory Healthcare outpatient cardiology clinics. Participants will have physical exams, blood tests, stress tests, exercise tests, surveys, questionnaires, and images taken of their hearts and blood vessels. They will be asked to take home devices to monitor their autonomic function, sleep, and track their mood, stress level, and symptoms for one week. Data and specimens will be saved for future research.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
CMD Group
Inclusion Criteria:
* Symptomatic postmenopausal women with chest pain
* age≥45 years old
* willing to undergo cardiac MIBG scan
* willing to undergo mental stress testing
* competent to give informed consent
Exclusion Criteria:
* Significant epicardial stenosis (defined by coronary st…
CMD Group
Inclusion Criteria:
* Symptomatic postmenopausal women with chest pain
* age≥45 years old
* willing to undergo cardiac MIBG scan
* willing to undergo mental stress testing
* competent to give informed consent
Exclusion Criteria:
* Significant epicardial stenosis (defined by coronary stenosis ≥ 70% in any epicardial coronary artery or hemodynamically significant stenosis determined by fractional flow reserve)
* Left ventricular systolic dysfunction (ejection fraction ≤ 50%)
* Heart failure with a preserved ejection fraction
* Significant anemia or blood dyscrasia
* Severe uncontrolled hypertension \>180/100
* Unable to lie flat for mental stress testing
* Pre-menopausal
* Pregnant
* Pericarditis/myocarditis
* History of percutaneous coronary intervention
* Coronary artery bypass grafting
* Acute myocardial infarction/acute coronary syndrome/unstable angina within 1 month
* Significant valvular disease, including aortic or mitral stenosis
* Sinus node dysfunction/pacemaker, 2nd or 3rd-degree atrioventricular block
* Severe lung, renal, liver, or psychiatric illness
* Current neoplasm
* History of substance abuse
* Acute illness such as infection in the previous 4 weeks
* Life-expectancy less than 2 years
* Unable to safely withdraw medications for mental stress testing
* Significant psychiatric illness that precludes safe participation in the study
* Conditions that preclude accurate or safe testing and patient refusal
* Unable to consent
Obstructive CAD (oCAD) Group
Inclusion Criteria:
* Symptomatic postmenopausal women with chest pain who have obstructive CAD in at least one epicardial coronary artery
* willing to undergo cardiac MIBG scan
* willing to undergo mental stress testing
* competent to give informed consent
Exclusion Criteria:
* Significant epicardial stenosis (defined by coronary stenosis ≥ 70% in any epicardial coronary artery or hemodynamically significant stenosis determined by fractional flow reserve)
* Left ventricular systolic dysfunction (ejection fraction ≤ 50%)
* Heart failure with a preserved ejection fraction
* Significant anemia or blood dyscrasia
* Severe uncontrolled hypertension \>180/100
* Unable to lie flat for mental stress testing
* Pre-menopausal
* Pregnant
* Pericarditis/myocarditis
* History of percutaneous coronary intervention
* Coronary artery bypass grafting
* Acute myocardial infarction/acute coronary syndrome/unstable angina within 1 month
* Significant valvular disease, including aortic or mitral stenosis
* Sinus node dysfunction/pacemaker, 2nd or 3rd-degree atrioventricular block
* Severe lung, renal, liver, or psychiatric illness
* Current neoplasm
* History of substance abuse
* Acute illness such as infection in the previous 4 weeks
* Life expectancy is less than 2 years
* Unable to safely withdraw medications for mental stress testing
* Significant psychiatric illness that precludes safe participation in the study
* Conditions that preclude accurate or safe testing and patient refusal
* Unable to consent
Asymptomatic Control Group
Inclusion Criteria:
* Asymptomatic postmenopausal women, age ≥ 45 years old
* Healthy volunteer with no cardiac risk factors
* No history or diagnosis of heart disease
* Not on any cardiac medications
* Normal maximal exercise treadmill stress testing (ETT)
* Fully understanding and willing to undergo mental stress testing
* Willing to sign the informed consent
Exclusion Criteria:
* Significant epicardial stenosis (defined by coronary stenosis ≥ 70% in any epicardial coronary artery or hemodynamically significant stenosis determined by fractional flow reserve)
* Left ventricular systolic dysfunction (ejection fraction ≤ 50%)
* Heart failure with a preserved ejection fraction
* Significant anemia or blood dyscrasia
* Severe uncontrolled hypertension \>180/100
* Unable to lie flat for mental stress testing
* Pre-menopausal
* Pregnant
* Pericarditis/myocarditis
* History of percutaneous coronary intervention
* Coronary artery bypass grafting
* Acute myocardial infarction/acute coronary syndrome/unstable angina within 1 month
* Significant valvular disease, including aortic or mitral stenosis
* Sinus node dysfunction/pacemaker, 2nd or 3rd-degree atrioventricular block
* Severe lung, renal, liver, or psychiatric illness
* Current neoplasm
* History of substance abuse
* Acute illness such as infection in the previous 4 weeks
* Life expectancy is less than 2 years
* Unable to safely withdraw medications for mental stress testing
* Significant psychiatric illness that precludes safe participation in the study
* Orthopedic limitation that will prevent ETT
* LDL \>120 mg/dL
* Fasting blood glucose \>95 mg/dL
* Hypertension, defined as resting BP \>120/80
* Diabetes
* Hyperlipidemia
* Smoking
* Conditions that preclude accurate or safe testing and patient refusal
* Unable to consent
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.